Background: Routine ABO blood group typing for pre-transfusion testing of a male Austrian patient of Far Eastern origin showed discrepant results with an apparently weak blood group B phenotype and irregular anti-B. Materials and Methods: ABH phenotyping and cross-matching was done by standard serologic techniques and levels of H expression were determined by flow cytometry. ABO gene sequencing including regulatory regions as well as analysis of FUT1 (H), FUT2 (Secretor), and FUT3 (Lewis) were carried out. Results: While monoclonal ABO antigen typing indicated blood group O, weak agglutination reactions using polyclonal human anti-B and anti-AB were seen. In reverse typing at room temperature, the plasma was reactive with A1 and A2 RBCs and negative with B and O cells, whereas at 4°C, anti-B reactivity was found. The indirect anti-globulin cross-match of the patient’s plasma was positive with group B RBCs and negative with group O RBCs. Sequencing analysis showed the presence of ABO*B.01 (B114) allele and homozygosity for the FUT1 mutation c.551_552delAG. Flow cytometry demonstrated trace amounts of H antigen on the patient’s RBCs. Conclusion: While a functional B allele was found, analysis of FUT1 and FUT2 genes revealed the presence of a rare para-Bombay genotype OhB. Interestingly, no anti-H but irregular anti-B was found in the patient’s plasma, responsible for the positive cross-match with group B RBCs. Even though very rare and not reported for the European population, the presence of an H-deficient phenotype should be considered when investigating individuals with an unusual ABO blood group type.

1.
Larsen
RD
,
Ernst
LK
,
Nair
RP
,
Lowe
JB
.
Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen
.
Proc Natl Acad Sci USA
.
1990
Sep
;
87
(
17
):
6674
8
.
[PubMed]
0027-8424
2.
Kelly
RJ
,
Rouquier
S
,
Giorgi
D
,
Lennon
GG
,
Lowe
JB
.
Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype
.
J Biol Chem
.
1995
Mar
;
270
(
9
):
4640
9
.
[PubMed]
0021-9258
3.
Wagner
FF
,
Flegel
WA
.
Polymorphism of the h allele and the population frequency of sporadic nonfunctional alleles
.
Transfusion
.
1997
Mar
;
37
(
3
):
284
90
.
[PubMed]
0041-1132
4.
Koda
Y
,
Soejima
M
,
Kimura
H
.
The polymorphisms of fucosyltransferases
.
Leg Med (Tokyo)
.
2001
Mar
;
3
(
1
):
2
14
.
[PubMed]
1344-6223
5.
Pang
H
,
Koda
Y
,
Soejima
M
,
Fujitani
N
,
Ogaki
T
,
Saito
A
, et al.
Polymorphism of the human ABO-Secretor locus (FUT2) in four populations in Asia: indication of distinct Asian subpopulations
.
Ann Hum Genet
.
2001
Sep
;
65
(
Pt 5
):
429
37
.
[PubMed]
0003-4800
6.
Matzhold
EM
,
Helmberg
W
,
Wagner
T
,
Drexler
C
,
Ulrich
S
,
Winkler
A
, et al.
Identification of 14 new alleles at the fucosyltransferase 1, 2, and 3 loci in Styrian blood donors, Austria
.
Transfusion
.
2009
Oct
;
49
(
10
):
2097
108
.
[PubMed]
0041-1132
7.
Storry
JR
,
Johannesson
JS
,
Poole
J
,
Strindberg
J
,
Rodrigues
MJ
,
Yahalom
V
, et al.
Identification of six new alleles at the FUT1 and FUT2 loci in ethnically diverse individuals with Bombay and Para-Bombay phenotypes
.
Transfusion
.
2006
Dec
;
46
(
12
):
2149
55
.
[PubMed]
0041-1132
8.
Gassner
C
,
Utz
I
,
Schennach
H
,
Ramoni
A
,
Steiner
H
,
Scholz
S
, et al.
Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76
.
Transfusion
.
2013
Nov
;
53
(
11
Suppl 2
):
2954
9
.
[PubMed]
1537-2995
9.
Matzhold
EM
,
Drexler
C
,
Staudacher
E
,
Glock
B
,
Wagner
T
.
A novel variant B allele at the ABO gene locus characterized by a duplication-based insertion of 27 nucleotides identified in an Iraqi male with a weak B subgroup phenotype
.
Transfusion
.
2018
May
;
58
(
5
):
1318
9
.
[PubMed]
0041-1132
10.
Yu
LC
,
Yang
YH
,
Broadberry
RE
,
Chen
YH
,
Lin
M
.
Heterogeneity of the human H blood group alpha(1,2)fucosyltransferase gene among para-Bombay individuals
.
Vox Sang
.
1997
;
72
(
1
):
36
40
.
[PubMed]
0042-9007
11.
Yu
LC
,
Yang
YH
,
Broadberry
RE
,
Chen
YH
,
Chan
YS
,
Lin
M
.
Correlation of a missense mutation in the human Secretor alpha 1,2-fucosyltransferase gene with the Lewis(a+b+) phenotype: a potential molecular basis for the weak Secretor allele (Sew)
.
Biochem J
.
1995
Dec
;
312
(
Pt 2
):
329
32
.
[PubMed]
0264-6021
12.
Mollicone
R
,
Reguigne
I
,
Kelly
RJ
,
Fletcher
A
,
Watt
J
,
Chatfield
S
, et al.
Molecular basis for Lewis alpha(1,3/1,4)-fucosyltransferase gene deficiency (FUT3) found in Lewis-negative Indonesian pedigrees
.
J Biol Chem
.
1994
Aug
;
269
(
33
):
20987
94
.
[PubMed]
0021-9258
13.
Koda
Y
,
Kimura
H
,
Mekada
E
.
Analysis of Lewis fucosyltransferase genes from the human gastric mucosa of Lewis-positive and -negative individuals
.
Blood
.
1993
Nov
;
82
(
9
):
2915
9
.
[PubMed]
0006-4971
14.
Dzierzkowa-Borodej
W
,
Meinhard
W
,
Nestorowicz
S
,
Piróg
J
.
Successful elution of anti-A and certain anti-H reagents from two “Bombay” (O A H ) blood samples and investigation of isoagglutinins in their sera
.
Arch Immunol Ther Exp (Warsz)
.
1972
;
20
(
6
):
841
9
.
[PubMed]
0004-069X
15.
Rodier
L
,
Lopez
M
,
Liberge
G
,
Badet
J
,
Gerbal
A
,
Salmon
C
.
Anti-h absorbed by, and eluted from Oh (Bombay) red blood cells
.
Biomedicine
.
1974
Jul
;
21
(
7
):
312
6
.
[PubMed]
0300-0893
16.
Yan
L
,
Zhu
F
,
Xu
X
,
Hong
X
,
Lv
Q
.
Molecular basis for para-Bombay phenotypes in Chinese persons, including a novel nonfunctional FUT1 allele
.
Transfusion
.
2005
May
;
45
(
5
):
725
30
.
[PubMed]
0041-1132
17.
Mak
KH
,
Lubenko
A
,
Greenwell
P
,
Voak
D
,
Yan
KF
,
Poole
J
.
Serologic characteristics of H-deficient phenotypes among Chinese in Hong Kong
.
Transfusion
.
1996
Nov-Dec
;
36
(
11-12
):
994
9
.
[PubMed]
0041-1132
18.
Chen
DP
,
Tseng
CP
,
Wang
WT
,
Peng
CT
,
Tsao
KC
,
Wu
TL
, et al.
Two prevalent h alleles in para-Bombay haplotypes among 250,000 Taiwanese
.
Ann Clin Lab Sci
.
2004
;
34
(
3
):
314
8
.
[PubMed]
0091-7370
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.